Hypermethylation of miR-107, miR-130b, miR-203a, miR-1258 Genes Associated with Ovarian Cancer Development and Metastasis


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

It is known that microRNAs (miRNAs) are able to dynamically regulate gene expression. At the same time, methylation can reduce expression of miRNA encoding genes and, therefore, reduce their inhibitory effects on mRNAs of target genes, including those of oncogenes, that promoting the development of tumors of different localization. The role of miRNA hypermethylation in the pathogenesis of ovarian cancer is not completely understood; so we conducted a search for new hypermethylated and potentially suppressor miRNA genes in ovarian tumors. Four new miRNA genes (MIR-107, MIR-130b, MIR-203a, MIR-1258) commonly hypermethylated (28‒52% ) in tumor tissues vs 4‒7% in paired histologically normal tissues, p < 0.01, were identified in a representative set of 54 ovarian cancer samples using methylation-specific PCR. It was shown that hypermethylation of MIR-130b, MIR-203a, and MIR-1258 genes is significantly (p ≤ 0.05) associated with metastasis of ovarian cancer. These results suggest the involvement of four miRNAs (miR-107, miR-130b, miR-203a, and miR-1258) and hypermethylation of their encoding genes in the pathogenesis of ovarian cancer.

About the authors

V. I. Loginov

Institute of General Pathology and Pathophysiology; Research Center of Medical Genetics

Author for correspondence.
Email: loginov7w@gmail.com
Russian Federation, Moscowa, 125315; Moscow, 115478

A. M. Burdennyy

Institute of General Pathology and Pathophysiology

Email: eleonora10_45@mail.ru
Russian Federation, Moscowa, 125315

E. A. Filippova

Institute of General Pathology and Pathophysiology

Email: eleonora10_45@mail.ru
Russian Federation, Moscowa, 125315

I. V. Pronina

Institute of General Pathology and Pathophysiology

Email: eleonora10_45@mail.ru
Russian Federation, Moscowa, 125315

T. P. Kazubskaya

Blokhin Russian Cancer Research Center

Email: eleonora10_45@mail.ru
Russian Federation, Moscow, 115478

D. N. Kushlinsky

Blokhin Russian Cancer Research Center

Email: eleonora10_45@mail.ru
Russian Federation, Moscow, 115478

V. D. Ermilova

Blokhin Russian Cancer Research Center

Email: eleonora10_45@mail.ru
Russian Federation, Moscow, 115478

S. V. Rykov

State Research Institute for Genetics and Selection of Industrial Microorganisms,
Kurchatov Institute National Research Center

Email: eleonora10_45@mail.ru
Russian Federation, Moscow, 117545

D. S. Khodyrev

State Research Institute for Genetics and Selection of Industrial Microorganisms,
Kurchatov Institute National Research Center; Federal Research Clinical Center of Specialized Types of Medical Care and Medical Technologies,
Federal Biomedical Agency of Russia

Email: eleonora10_45@mail.ru
Russian Federation, Moscow, 117545; Moscow, 115682

E. A. Braga

Institute of General Pathology and Pathophysiology; Research Center of Medical Genetics

Author for correspondence.
Email: eleonora10_45@mail.ru
Russian Federation, Moscowa, 125315; Moscow, 115478

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2018 Pleiades Publishing, Inc.